Rapiscan 400 µg/ 5 ml
As listed in the register: Rapiscan 400 µg/ 5 ml, Injektionslösung
400 µg/ 5 ml ·
- Prescription only
- Heart, blood pressure and circulation
- Active substance
- Regadenosonum
- Made by
- GE Healthcare AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Koronarer Vasodilatator der anstelle von Stressübungen für Myokardperfusionsaufnahmen mit Radionukliden angewendet wird.
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | GE Healthcare AG |
|---|---|
| Active substance | Regadenosonum |
| Used in | Heart, blood pressure and circulation |
| Strength | 400 µg/ 5 ml |
| Classification | C01EB21 · Heart, blood pressure and circulation |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Rapiscan 400 µg/ 5 ml, Injektionslösung |
| Packs | 1 Durchstechflasche(n) |
| Zulassungsnummer | 66137 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.